News & Views | Published:


Copy number signatures in ovarian cancer


A new study uncovers novel copy number signatures in ovarian cancer genomes. This work sheds light on mutational processes driving ovarian cancer, reveals the distribution of copy number features across the patient population and identifies new genomic properties related to treatment response.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Cancer Genome Atlas Research Network. Nature 474, 609–615 (2011).

  2. 2.

    McIntyre, G. et al. Nat. Genet. (2018).

  3. 3.

    Patch, A.-M. et al. Nature 521, 489–494 (2015).

  4. 4.

    McPherson, A. et al. Nat. Genet. 48, 758–767 (2016).

  5. 5.

    Wang, Y. K. et al. Nat. Genet. 49, 856–865 (2017).

  6. 6.

    Davies, H. et al. Nat. Med. 23, 517–525 (2017).

  7. 7.

    Alexandrov, L. B. et al. Nature 500, 415–421 (2013).

Download references

Author information

Competing Interests

S.P.S. is a principal shareholder of Contextual Genomics, Inc.

Correspondence to Sohrab P. Shah.

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article

Fig. 1: Active copy number signatures over time create a composite portrait that can be observed with genome sequencing.